REGISTER RECORD · clinicaltrials.gov
NCT01624805
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
AS THE REGISTER RECORDS IT
Status and dates
| Status as listed | RECRUITING: currently recruiting participants |
|---|---|
| Register last updated | 2026-06-22 |
| Retrieved by this site | 2026-08-31 |
| Source | https://clinicaltrials.gov/study/NCT01624805 |
What this record shows
This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.